Organization, Functions, and Delegations of Authority; Part G; Indian Health Service; Headquarters, Office of the Director, Office of Quality, 106537-106539 [2024-31273]
Download as PDF
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 249 / Monday, December 30, 2024 / Notices
Committee (referred to as the ‘‘HITAC’’).
The HITAC will be governed by the
provisions of the Federal Advisory
Committee Act (FACA) (Pub. L. 92–
463), as amended, (5 U.S.C. app.), which
sets forth standards for the formation
and use of federal advisory committees.
Composition: The HITAC is
comprised of at least 25 members, of
which:
• No fewer than 2 members are
advocates for patients or consumers of
health information technology;
• 3 members are appointed by the
HHS Secretary
Æ 1 of whom shall be appointed to
represent the Department of Health and
Human Services; and
Æ 1 of whom shall be a public health
official;
• 2 members are appointed by the
majority leader of the Senate;
• 2 members are appointed by the
minority leader of the Senate;
• 2 members are appointed by the
Speaker of the House of Representatives;
• 2 members are appointed by the
minority leader of the House of
Representatives;
• Other members are appointed by
the Comptroller General of the United
States.
Members serve for one-, two-, or
three-year terms. All members may be
reappointed for a subsequent three-year
term. Each member is limited to two
three-year terms, not to exceed six years
of service. Members serve without pay
but will be provided per-diem and
travel costs for committee services, if
warranted.
Recommendations: The HITAC
recommendations to the Assistant
Secretary for Technology Policy/
National Coordinator for Health
Information Technology are publicly
available at https://www.healthit.gov/
topic/federal-advisory-committees/
recommendations-national-coordinatorhealth-it.
Public Meetings: All HITAC meetings
will be virtual. Please note that some
HITAC meetings may also have an inperson meeting option. For web
conference instructions and the most
up-to-date information, including inperson meeting location (if applicable),
please visit the HITAC calendar on the
ONC website, www.healthit.gov/topic/
federal-advisory-committees/hitaccalendar.
The schedule of meetings to be held
in 2025 is as follows:
• February 13, 2025, from
approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
• March 20, 2025, from
approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
VerDate Sep<11>2014
23:58 Dec 27, 2024
Jkt 265001
• April 10, 2025, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
• May 8, 2025, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
• June 12, 2025, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
• July 17, 2025, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
• August 14, 2025, from
approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
• September 18, 2025, from
approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
• October 16, 2025, from
approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
• November 13, 2025, from
approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
All meetings are open to the public.
Additional meetings may be scheduled
as needed.
Contact Person for Meetings: Seth
Pazinski, Seth.Pazinski@hhs.gov. A
notice in the Federal Register about last
minute modifications that impact a
previously announced advisory
committee meeting cannot always be
published quickly enough to provide
timely notice. Please email Seth
Pazinski for the most current
information about meetings.
Agenda: As outlined in the 21st
Century Cures Act, the HITAC will
develop and submit recommendations
to the Assistant Secretary for
Technology Policy/National Coordinator
on Health Information Technology on
the topics of interoperability, privacy
and security, patient access to
information, use of technologies that
support public health, design and use of
technologies that advance health equity,
and use of artificial intelligence that
improves health and health care. In
addition, the committee will also
address any administrative matters and
hear periodic reports from ASTP. ASTP
intends to make background material
available to the public no later than 24
hours prior to the meeting start time. If
ASTP is unable to post the background
material on its website prior to the
meeting, the material will be made
publicly available on ASTP’s website
after the meeting, at www.healthit.gov/
hitac.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person prior to the meeting date. An
oral public comment period will be
scheduled at each meeting. Time
allotted for each commenter will be
limited to three minutes. If the number
of speakers requesting to comment is
PO 00000
Frm 00132
Fmt 4703
Sfmt 4703
106537
greater than can be reasonably
accommodated during the scheduled
public comment period, ASTP will take
written comments after the meeting.
ASTP welcomes the attendance of the
public at its HITAC meetings. If you
require special accommodations due to
a disability, please contact Seth Pazinski
at least seven (7) days in advance of the
meeting.
Notice of these meetings are given
under the Federal Advisory Committee
Act (Pub. L. No. 92–463, 5 U.S.C., App.
2).
Dated: November 22, 2024.
Stanley S. Pazinski,
Designated Federal Officer, Assistant
Secretary for Technology Policy/Office of the
National Coordinator for Health Information
Technology.
[FR Doc. 2024–31076 Filed 12–27–24; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Organization, Functions, and
Delegations of Authority; Part G;
Indian Health Service; Headquarters,
Office of the Director, Office of Quality
Indian Health Service,
Department of Health and Human
Services.
ACTION: Final notice.
AGENCY:
Part G of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (HHS) is hereby amended to
reflect a reorganization of the Indian
Health Service (IHS). The purpose of
this reorganization proposal is to update
the current approved IHS, Office of the
Director (GA), Congressional and
Legislative Affairs Staff (GA1) and the
Office of Quality (GAP) in their entirety
and replace with the following:
SUPPLEMENTARY INFORMATION: The IHS is
an Operating Division within the
Department of Health and Human
Services (HHS) and is under the
leadership and direction of a Director
who is directly responsible to the
Secretary of Health and Human
Services. The IHS Headquarters is
proposing to reorganize the following
major component: Office the Office of
Quality (OQ).
Part G of the Statement of
Organization, Functions, and
Delegations of Authority was most
recently amended at 89 FR 61126, July
30, 2024.
SUMMARY:
E:\FR\FM\30DEN1.SGM
30DEN1
106538
Federal Register / Vol. 89, No. 249 / Monday, December 30, 2024 / Notices
Office of the Director, IHS (GA)
ddrumheller on DSK120RN23PROD with NOTICES1
Congressional and Legislative Affairs
Staff (CLAS) (GA1)
(1) Serves as the principal advisor to
the IHS Director on all legislative and
congressional relations matters; (2)
advises the IHS Director and other IHS
officials on the need for changes in
legislation and manages the
development of IHS legislative
initiatives; (3) serves as the IHS liaison
office for congressional and legislative
affairs with Congressional offices, the
HHS, the Office of Management and
Budget (OMB), the White House, and
other federal agencies; (4) tracks all
major legislative proposals in the
Congress that would impact Indian
health; (5) ensures that the IHS Director
and appropriate IHS and HHS officials
are briefed on the potential impact of
proposed legislation; (6) develops
legislative strategy for key policy and
legislative initiatives; (7) provides
technical assistance and advice relative
to the effect that initiatives/
implementation would have on the IHS;
(8) provides support and collaborates
with the Office of Finance and
Accounting relative to IHS
appropriations efforts; (9) directs the
development of IHS briefing materials
for congressional hearings, testimony,
and bill reports; (10) analyzes legislation
for necessary action within the IHS; (11)
develops appropriate legislative
implementation plans; (12) coordinates
with IHS HQ and Area Offices as
appropriate to provide leadership,
advocacy, and technical support to
respond to requests from the public,
including tribal governments, tribal
organizations, and Indian community
organizations regarding IHS legislative
issues.
Office of Quality (GAP)
The Office of Quality (OQ) provides
leadership and direction for quality
improvement and patient safety
activities and oversees compliance and
risk management throughout the agency.
Specifically, the office (1) advises the
Indian Health Service (IHS) Director on
assuring quality health care, maximizing
the patient experience, and
systematizing quality improvement
activities to improve clinical outcomes
and administrative processes; (2)
develops and implements a strategic
quality framework; (3) oversees
accreditation readiness activities and
compliance with accreditation
requirements at all IHS Direct Service
facilities; (4) conducts performance
improvement, quality assurance,
innovative thinking, and risk
management trainings; (5) oversees IHS
VerDate Sep<11>2014
23:58 Dec 27, 2024
Jkt 265001
facilities and staff in intra-agency
quality improvement activities; (6)
advises on development and monitoring
of quality assurance and governance
metrics for health care delivery
processes and outcomes; (7) develops
programs to assess, address, and
improve systems and processes to
improve health care quality; (8) advises
on compliance with relevant federal
regulations and accreditation and
professional standards; (9) provides
guidance for standardization of health
care delivery policies, protocols, and
governance; (10) advises and guides IHS
patient-centered care processes,
ensuring engagement of patients as
partners in care; (11) oversees the IHS
Enterprise Risk Management (ERM)
vision, culture, strategy, and framework
and clinical risk management; (12)
oversees and coordinates the agency’s
efforts to establish and maintain proper
internal controls; (13) ensures
requirements are met under OMB
Circular A–123; (14) develops programs
to promote patient safety management
and reporting systems and processes,
sentinel event investigations/root cause
analysis; and (15) participates in crosscutting issues and processes, including
but not limited to, emergency
preparedness/security, quality
assurance, recruitment, budget
formulation, self-determination issues,
and resolution of audit findings as may
be needed and appropriate.
Division of Quality Assurance and
Patient Safety (GAPA)
(1) Develops and implements
programs to promote sustained
compliance with relevant federal
regulations related to accreditation and
professional standards for health care
facilities; (2) manages and coordinates
continuous accreditation compliance
programs using multidisciplinary
integration of survey readiness
activities; (3) coordinates health care
accreditation resource management; (4)
tracks health care accreditation and
certification survey reports; (5) develops
and implements programs to manage
credentialing standards and policy,
acquires and maintains centralized
credentialing software system, promotes
unification of medical staff
professionals (MSP), and promotes
standardized training and support
resources for MSP; (6) develops and
implements policies and procedures to
promote patient safety, infection control
practices, and environment of care and
life safety practices; (7) establishes
policies and guidelines to reduce
adverse events; (8) develops education
and training related to the application of
established patient safety and adverse
PO 00000
Frm 00133
Fmt 4703
Sfmt 4703
event reporting systems and metrics; (9)
establishes and maintains oversight
mechanisms for incident identification
and reporting, adverse events and good
catches, comprehensive systemic
analysis/root cause analysis process and
documentation; (10) implements
strategies to improve patient and
workforce safety; (11) enhances
collaborative communication to
facilitate the sharing of best practices
and learning related to identified risks
and mitigation actions across the
agency; (12) identifies IHS and National
patient safety trends and investigates
positive and negative patient safety
outcomes across the agency; and (13)
provides patient safety consultation
regarding industry standards, best
practices, and development of policy,
processes, and procedures.
Division of Enterprise Risk
Management (GAPB)
(1) Oversees and coordinates the IHS
ERM vision, culture, strategy, and
framework; (2) develops goals and
objectives for the ERM program,
integrated with broader IHS-wide
strategic goals/objectives, and tracks
progress toward achieving them; (3)
coordinates the development of risk
policy, including a risk appetite
statement, to guide Agency decisionmaking and documentation related to
risk; (4) advises and collaborates in the
development of the IHS ERM portfolio
of enterprise risks and ensures
appropriate and effective management
by accountable individual risk owners;
(5) integrates risk assessment activities
across the IHS risk portfolio; (6) advises
on ERM and provides expertise, advice,
and assistance to the agency leadership
on compliance matters; (7) provides
guidance and training on the risk
management process and prioritization;
(8) facilitates the governance policy,
process, and reporting to establish
consistency and quality of
documentation of fiduciary
responsibilities of governing bodies; (9)
oversees tracking of high-risk
administrative, clinical, or personnel
incidents to ensure appropriate local
and agency-wide response, timely
closure, assessment of internal controls,
and review of case studies to promote a
safety culture based on risk-awareness;
(10) collaborates with key HQ Offices to
ensure consistency in cross-cutting
agency strategic planning, ERM, and
management of internal controls across
IHS; (11) collaborates with strategic
planning process to integrate risk
management and strategic thinking; (12)
reviews tort claims files; (13) represents
the IHS when claims are presented for
review by the Malpractice Claims
E:\FR\FM\30DEN1.SGM
30DEN1
Federal Register / Vol. 89, No. 249 / Monday, December 30, 2024 / Notices
Review Panel chartered by the HHS, and
assists providers with Malpractice
Claims Review Panel interactions; (14)
submits payment reports to the National
Practitioner Data Bank; (15) maintains
case files and a malpractice claims
database; (16) provides case summaries,
peer review, outcome information, and
feedback of risk management
recommendations; (17) disseminates
information about the review process;
(18) responds to outside organizations
requesting tort claim-involvement
histories on former employees; and (19)
responds to Tort Claims inquiries from
governmental agencies, media, Tribal
and Urban Indian organizations, and
advocacy groups with the Office of
General Council guidance.
ddrumheller on DSK120RN23PROD with NOTICES1
Division of Innovation and
Improvement (GAPC)
(1) Provides trainings on innovative
thinking and performance improvement
techniques; (2) provides training on
empathy and relational intelligence to
better understand colleagues and
stakeholders and maximize teamwork;
(3) integrates innovative thinking into
quality improvement and policy
formation processes to stimulate rapid
idea generation; (4) oversees training
programs to increase quality
improvement capacity and standardize
improvement methodology to test smallscale changes at the local level; (5)
reviews use of health information
technology and data to improve
performance, quality and service; (6)
monitors patient and staff satisfaction
with health care service delivery; (7)
leads change management for practice
transformation to embrace new models
of care delivery and to enhance
efficiency of the care delivery process;
(8) develops programs to promote the
implementation of patient-centered care
models; (9) coordinates sharing of best
practices between Area Quality
Managers and Service Unit Quality
Assurance and Performance
Improvement officers; and (10) supports
and promotes patient-centered care
including Patient and Family
Engagement, and promotes unification
of Area Quality Managers and Service
Unit Quality Assurance and
Performance Improvement Officers.
Division of Compliance (GAPD)
(1) Coordinates the IHS’s compliance
program; (2) administers the agency’s
internal control program in accordance
with the Federal Managers’ Financial
Integrity Act, OMB Circular No. A–123,
GAO Green Book, and other applicable
requirements; (3) oversees and
coordinates the agency’s efforts to
establish and maintain proper internal
VerDate Sep<11>2014
23:58 Dec 27, 2024
Jkt 265001
controls; (4) oversees and
institutionalizes a continuous
compliance review process; (5) manages
goals and objectives for the Compliance
program, integrates them with broader
IHS-wide strategic goals/objectives, and
tracks progress toward achieving them;
(6) evaluates and monitors systems of
internal control across IHS and uses the
assessments of the internal control
program as an integral part of ERM to
effectively manage risks across IHS; (7)
Serves as the IHS liaison office to the
Government Accountability Office
(GAO) and Office of Inspector General
(OIG); (8) coordinates the development,
clearance, and transmittal of IHS
responses and follow-up to reports
issued by the OIG, the GAO, and other
federal internal and external authorities
reviewing risk management and internal
controls; (9) provides leadership and
direction on activities for continuous
improvement of management
accountability and administrative
systems for effective and efficient
program support services IHS-wide; and
(10) oversees and coordinates the
annual development and submission of
the agency’s federal Activities Inventory
Reform Act report to the HHS.
Section GA–30, Indian Health Service—
Delegations of Authority
All delegations of authority and redelegations of authority made to IHS
officials that were in effect immediately
prior to this reorganization, and that are
consistent with this reorganization,
shall continue in effect pending further
re-delegation.
Roselyn Tso,
Director, Indian Health Service.
[FR Doc. 2024–31273 Filed 12–27–24; 8:45 am]
BILLING CODE 4166–14–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
PO 00000
Frm 00134
Fmt 4703
Sfmt 4703
106539
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; NHP Review.
Date: January 31, 2025.
Time: 10:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute on Aging, 5601
Fishers Lane, Suite 8B, Rockville, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Bita Nakhai, Ph.D.,
Scientific Review Officer, National Institute
on Aging, National Institutes of Health, 5601
Fishers Lane, Suite 8B, Rockville, MD 20852,
(301) 402–7701, nakhaib@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 19, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–30880 Filed 12–27–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Initial Review
Group Training and Workforce Development
Study Section—C Training & Workforce
Development Study Section C (TWD–C)
Review of applications for the B2B &
IRACDA Programs and Scientific Meetings &
Conferences.
Date: February 20–21, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892.
Meeting Format: Virtual Meeting.
Contact Person: Sonia Ivette OrtizMiranda, Ph.D., Scientific Review Officer,
E:\FR\FM\30DEN1.SGM
30DEN1
Agencies
[Federal Register Volume 89, Number 249 (Monday, December 30, 2024)]
[Notices]
[Pages 106537-106539]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-31273]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Indian Health Service
Organization, Functions, and Delegations of Authority; Part G;
Indian Health Service; Headquarters, Office of the Director, Office of
Quality
AGENCY: Indian Health Service, Department of Health and Human Services.
ACTION: Final notice.
-----------------------------------------------------------------------
SUMMARY: Part G of the Statement of Organization, Functions, and
Delegations of Authority of the Department of Health and Human Services
(HHS) is hereby amended to reflect a reorganization of the Indian
Health Service (IHS). The purpose of this reorganization proposal is to
update the current approved IHS, Office of the Director (GA),
Congressional and Legislative Affairs Staff (GA1) and the Office of
Quality (GAP) in their entirety and replace with the following:
SUPPLEMENTARY INFORMATION: The IHS is an Operating Division within the
Department of Health and Human Services (HHS) and is under the
leadership and direction of a Director who is directly responsible to
the Secretary of Health and Human Services. The IHS Headquarters is
proposing to reorganize the following major component: Office the
Office of Quality (OQ).
Part G of the Statement of Organization, Functions, and Delegations
of Authority was most recently amended at 89 FR 61126, July 30, 2024.
[[Page 106538]]
Office of the Director, IHS (GA)
Congressional and Legislative Affairs Staff (CLAS) (GA1)
(1) Serves as the principal advisor to the IHS Director on all
legislative and congressional relations matters; (2) advises the IHS
Director and other IHS officials on the need for changes in legislation
and manages the development of IHS legislative initiatives; (3) serves
as the IHS liaison office for congressional and legislative affairs
with Congressional offices, the HHS, the Office of Management and
Budget (OMB), the White House, and other federal agencies; (4) tracks
all major legislative proposals in the Congress that would impact
Indian health; (5) ensures that the IHS Director and appropriate IHS
and HHS officials are briefed on the potential impact of proposed
legislation; (6) develops legislative strategy for key policy and
legislative initiatives; (7) provides technical assistance and advice
relative to the effect that initiatives/implementation would have on
the IHS; (8) provides support and collaborates with the Office of
Finance and Accounting relative to IHS appropriations efforts; (9)
directs the development of IHS briefing materials for congressional
hearings, testimony, and bill reports; (10) analyzes legislation for
necessary action within the IHS; (11) develops appropriate legislative
implementation plans; (12) coordinates with IHS HQ and Area Offices as
appropriate to provide leadership, advocacy, and technical support to
respond to requests from the public, including tribal governments,
tribal organizations, and Indian community organizations regarding IHS
legislative issues.
Office of Quality (GAP)
The Office of Quality (OQ) provides leadership and direction for
quality improvement and patient safety activities and oversees
compliance and risk management throughout the agency. Specifically, the
office (1) advises the Indian Health Service (IHS) Director on assuring
quality health care, maximizing the patient experience, and
systematizing quality improvement activities to improve clinical
outcomes and administrative processes; (2) develops and implements a
strategic quality framework; (3) oversees accreditation readiness
activities and compliance with accreditation requirements at all IHS
Direct Service facilities; (4) conducts performance improvement,
quality assurance, innovative thinking, and risk management trainings;
(5) oversees IHS facilities and staff in intra-agency quality
improvement activities; (6) advises on development and monitoring of
quality assurance and governance metrics for health care delivery
processes and outcomes; (7) develops programs to assess, address, and
improve systems and processes to improve health care quality; (8)
advises on compliance with relevant federal regulations and
accreditation and professional standards; (9) provides guidance for
standardization of health care delivery policies, protocols, and
governance; (10) advises and guides IHS patient-centered care
processes, ensuring engagement of patients as partners in care; (11)
oversees the IHS Enterprise Risk Management (ERM) vision, culture,
strategy, and framework and clinical risk management; (12) oversees and
coordinates the agency's efforts to establish and maintain proper
internal controls; (13) ensures requirements are met under OMB Circular
A-123; (14) develops programs to promote patient safety management and
reporting systems and processes, sentinel event investigations/root
cause analysis; and (15) participates in cross-cutting issues and
processes, including but not limited to, emergency preparedness/
security, quality assurance, recruitment, budget formulation, self-
determination issues, and resolution of audit findings as may be needed
and appropriate.
Division of Quality Assurance and Patient Safety (GAPA)
(1) Develops and implements programs to promote sustained
compliance with relevant federal regulations related to accreditation
and professional standards for health care facilities; (2) manages and
coordinates continuous accreditation compliance programs using
multidisciplinary integration of survey readiness activities; (3)
coordinates health care accreditation resource management; (4) tracks
health care accreditation and certification survey reports; (5)
develops and implements programs to manage credentialing standards and
policy, acquires and maintains centralized credentialing software
system, promotes unification of medical staff professionals (MSP), and
promotes standardized training and support resources for MSP; (6)
develops and implements policies and procedures to promote patient
safety, infection control practices, and environment of care and life
safety practices; (7) establishes policies and guidelines to reduce
adverse events; (8) develops education and training related to the
application of established patient safety and adverse event reporting
systems and metrics; (9) establishes and maintains oversight mechanisms
for incident identification and reporting, adverse events and good
catches, comprehensive systemic analysis/root cause analysis process
and documentation; (10) implements strategies to improve patient and
workforce safety; (11) enhances collaborative communication to
facilitate the sharing of best practices and learning related to
identified risks and mitigation actions across the agency; (12)
identifies IHS and National patient safety trends and investigates
positive and negative patient safety outcomes across the agency; and
(13) provides patient safety consultation regarding industry standards,
best practices, and development of policy, processes, and procedures.
Division of Enterprise Risk Management (GAPB)
(1) Oversees and coordinates the IHS ERM vision, culture, strategy,
and framework; (2) develops goals and objectives for the ERM program,
integrated with broader IHS-wide strategic goals/objectives, and tracks
progress toward achieving them; (3) coordinates the development of risk
policy, including a risk appetite statement, to guide Agency decision-
making and documentation related to risk; (4) advises and collaborates
in the development of the IHS ERM portfolio of enterprise risks and
ensures appropriate and effective management by accountable individual
risk owners; (5) integrates risk assessment activities across the IHS
risk portfolio; (6) advises on ERM and provides expertise, advice, and
assistance to the agency leadership on compliance matters; (7) provides
guidance and training on the risk management process and
prioritization; (8) facilitates the governance policy, process, and
reporting to establish consistency and quality of documentation of
fiduciary responsibilities of governing bodies; (9) oversees tracking
of high-risk administrative, clinical, or personnel incidents to ensure
appropriate local and agency-wide response, timely closure, assessment
of internal controls, and review of case studies to promote a safety
culture based on risk-awareness; (10) collaborates with key HQ Offices
to ensure consistency in cross-cutting agency strategic planning, ERM,
and management of internal controls across IHS; (11) collaborates with
strategic planning process to integrate risk management and strategic
thinking; (12) reviews tort claims files; (13) represents the IHS when
claims are presented for review by the Malpractice Claims
[[Page 106539]]
Review Panel chartered by the HHS, and assists providers with
Malpractice Claims Review Panel interactions; (14) submits payment
reports to the National Practitioner Data Bank; (15) maintains case
files and a malpractice claims database; (16) provides case summaries,
peer review, outcome information, and feedback of risk management
recommendations; (17) disseminates information about the review
process; (18) responds to outside organizations requesting tort claim-
involvement histories on former employees; and (19) responds to Tort
Claims inquiries from governmental agencies, media, Tribal and Urban
Indian organizations, and advocacy groups with the Office of General
Council guidance.
Division of Innovation and Improvement (GAPC)
(1) Provides trainings on innovative thinking and performance
improvement techniques; (2) provides training on empathy and relational
intelligence to better understand colleagues and stakeholders and
maximize teamwork; (3) integrates innovative thinking into quality
improvement and policy formation processes to stimulate rapid idea
generation; (4) oversees training programs to increase quality
improvement capacity and standardize improvement methodology to test
small-scale changes at the local level; (5) reviews use of health
information technology and data to improve performance, quality and
service; (6) monitors patient and staff satisfaction with health care
service delivery; (7) leads change management for practice
transformation to embrace new models of care delivery and to enhance
efficiency of the care delivery process; (8) develops programs to
promote the implementation of patient-centered care models; (9)
coordinates sharing of best practices between Area Quality Managers and
Service Unit Quality Assurance and Performance Improvement officers;
and (10) supports and promotes patient-centered care including Patient
and Family Engagement, and promotes unification of Area Quality
Managers and Service Unit Quality Assurance and Performance Improvement
Officers.
Division of Compliance (GAPD)
(1) Coordinates the IHS's compliance program; (2) administers the
agency's internal control program in accordance with the Federal
Managers' Financial Integrity Act, OMB Circular No. A-123, GAO Green
Book, and other applicable requirements; (3) oversees and coordinates
the agency's efforts to establish and maintain proper internal
controls; (4) oversees and institutionalizes a continuous compliance
review process; (5) manages goals and objectives for the Compliance
program, integrates them with broader IHS-wide strategic goals/
objectives, and tracks progress toward achieving them; (6) evaluates
and monitors systems of internal control across IHS and uses the
assessments of the internal control program as an integral part of ERM
to effectively manage risks across IHS; (7) Serves as the IHS liaison
office to the Government Accountability Office (GAO) and Office of
Inspector General (OIG); (8) coordinates the development, clearance,
and transmittal of IHS responses and follow-up to reports issued by the
OIG, the GAO, and other federal internal and external authorities
reviewing risk management and internal controls; (9) provides
leadership and direction on activities for continuous improvement of
management accountability and administrative systems for effective and
efficient program support services IHS-wide; and (10) oversees and
coordinates the annual development and submission of the agency's
federal Activities Inventory Reform Act report to the HHS.
Section GA-30, Indian Health Service--Delegations of Authority
All delegations of authority and re-delegations of authority made
to IHS officials that were in effect immediately prior to this
reorganization, and that are consistent with this reorganization, shall
continue in effect pending further re-delegation.
Roselyn Tso,
Director, Indian Health Service.
[FR Doc. 2024-31273 Filed 12-27-24; 8:45 am]
BILLING CODE 4166-14-P